Microbot Medical Completes Final Closing of Preferred Investment Options, Raising Up to $92.2 Million in Gross Proceeds
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 07 2025
0mins
Should l Buy ?
Source: Globenewswire
Investment Options Exercise: Microbot Medical Inc. announced the final closing of its exercise of preferred investment options, resulting in the purchase of 13,989,115 shares of common stock across three tranches, generating approximately $29.2 million in gross proceeds.
Use of Proceeds: The company plans to utilize the net proceeds for the development and commercialization of its LIBERTY® Robotic System, potential acquisitions, and general corporate purposes, with additional potential gross proceeds of about $63 million from newly issued short-term preferred investment options.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
